WallStreetZenWallStreetZen

NASDAQ: ANIP
Ani Pharmaceuticals Inc Stock Ownership - Who owns Ani Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ani Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Meredith CookSR. VP GENERAL COUNSEL SEC.2025-12-12400$82.32
$32.93kSell
Renee P. TannenbaumDirector2025-12-051,800$81.15
$146.07kSell
Chad GassertSVP - CORP. DEV. STRATEGY2025-11-1394$88.00
$8.27kSell
Patrick D. WalshDirector2025-11-138,643$86.88
$750.90kSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2025-11-13400$87.27
$34.91kSell
Chad GassertSVP - CORP. DEV. STRATEGY2025-11-1214,642$89.07
$1.30MSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2025-10-13400$90.09
$36.04kSell
Krista DavisSVP CHIEF HR OFFICER2025-09-191,000$98.04
$98.04kSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2025-09-12400$98.42
$39.37kSell
Krista DavisSVP CHIEF HR OFFICER2025-09-121,710$97.71
$167.08kSell

1 of 7

ANIP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIP insiders and whales buy or sell their stock.

ANIP Shareholders

What type of owners hold Ani Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Meridian Venture Partners II LP83.39%18,737,728$1.51BInsider
Robert E. Brown Jr.75.52%16,967,490$1.36BInsider
Ross J. Mangano25.78%5,792,084$465.63MInsider
Blackrock Inc11.34%2,548,892$204.91MInstitution
Tracy Marshbanks10.27%2,308,568$185.59MInsider
Vanguard Group Inc5.69%1,277,470$102.70MInstitution
Victor A. Morgenstern4.17%936,014$75.25MInsider
State Street Corp3.17%711,708$57.21MInstitution
Global Alpha Capital Management Ltd2.81%630,590$50.69MInstitution
Ubs Group Ag2.63%589,874$47.42MInstitution

1 of 3

ANIP vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIP29.82%70.18%Net SellingNet Selling
PRGO64.25%35.75%Net BuyingNet Buying
HROW28.85%71.15%Net Selling
ALVO5.08%0.00%
PAHC43.60%56.40%Net SellingNet Selling
View Top Pharmaceutical Stocks

Ani Pharmaceuticals Stock Ownership FAQ

Who owns Ani Pharmaceuticals?

Ani Pharmaceuticals (NASDAQ: ANIP) is owned by 90.81% institutional shareholders, 213.73% Ani Pharmaceuticals insiders, and 0.00% retail investors. Meridian Venture Partners II LP is the largest individual Ani Pharmaceuticals shareholder, owning 18.74M shares representing 83.39% of the company. Meridian Venture Partners II LP's Ani Pharmaceuticals shares are currently valued at $1.51B.

If you're new to stock investing, here's how to buy Ani Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.